Summary
The product Proviron 25mg, manufactured by PHARM400, underwent independent testing to verify its authenticity and potency. The sample, submitted by the Manufacturer Pharmaqo Labs mrp@vitamins.to, was analyzed by Janoshik Analytical, a laboratory specializing in pharmaceutical quality control. The analysis measured the presence of Mesterolone, with a concentration of 29.96 mg, which is 19.84% above the labeled claim of 25 mg.
The testing process was conducted on 1 February 2024. While the results indicate overdosing, it is important to consider that the batch number was not provided, and the sample was submitted by the Manufacturer. Independent third-party testing remains critical to validate these findings comprehensively. This report serves as an educational resource to promote harm reduction and informed decision-making.
Detailed Report
Product Overview
- Manufacturer: Pharmaqo Labs
- Product Name: Proviron 25mg
- Active Ingredient: Mesterolone
- Batch Number: Unknown
- Expiration Date: Not provided
- Delivery Method: Oral
Sample Acquisition and Testing
- Task Number: #38152
- Testing Ordered: 25 January 2024
- Sample Received: 31 January 2024
- Analysis Conducted By: Janoshik Analytical
- Product Submitted By: Pharmaqo Labs (Manufacturer)
- Analysis Paid For By: Pharmaqo Labs (Manufacturer)
Testing Results
- Specification: 25 mg (as stated on the label)
- Measured Concentration: 29.96 mg
- Accuracy: 119.84% (19.84% above the label claim)
Verification Details
- Verification URL: https://janoshik.com/tests/38152_7Z7ZQP9N6TJ7
Evaluation of Manufacturer-Submitted Testing
This analysis highlights the overdosing of the tested product, with a measured concentration of 29.96 mg of Mesterolone. The absence of a batch number and the manufacturer-submitted nature of the sample warrant careful evaluation. Manufacturer may not always provide a representative sample of the product, raising questions about consistency across the broader market. While Janoshik Analytical is recognized for its transparency and rigorous testing protocols, these findings would benefit from independent validation through third-party testing across multiple batches.
Conclusion
The analysis confirms that Proviron 25mg is overdosed, with a measured concentration of 29.96 mg. This result reflects potential variability in the product’s quality control and underscores the importance of additional testing to ensure consistent dosing across the product line. This report is provided to support educational and harm reduction efforts, helping consumers make informed choices regarding anabolic steroid products.
Disclaimer
This report is published for educational and harm reduction purposes. Manufacturer-submitted testing may involve inherent biases; however, it can still provide useful data when critically assessed alongside third-party or independent results. Readers are encouraged to use this information responsibly.
